At a glance
View appendix tables for the National Diabetes Statistics Report.
Table 1
Appendix Table 1. Age-adjusted prevalence of diagnosed, undiagnosed, and total diabetes among adults aged 18 years or older, United States, 2017–2020.
| Characteristic | Diagnosed diabetes Percentage (95% CI) |
Undiagnosed diabetes Percentage (95% CI) |
Total diabetes Percentage (95% CI) |
|---|---|---|---|
| Total | 10.1 (9.2–11.0) | 3.1 (2.6–3.8) | 13.2 (12.0–14.5) |
| Sex | |||
| Men | 11.6 (10.3–13.0) | 2.7 (2.0–3.7) | 14.2 (12.7–15.9) |
| Women | 8.8 (7.6–10.2) | 3.6 (2.6–5.0) | 12.4 (10.5–14.6) |
| Race-ethnicity | |||
| White, Non-Hispanic | 8.9 (7.6–10.4) | 2.3 (1.5–3.5) | 11.2 (9.5–13.2) |
| Black, Non-Hispanic | 12.4 (10.8–14.1) | 4.4 (3.2–6.2) | 16.8 (15.3–18.5) |
| Asian, Non-Hispanic | 11.1 (9.7–12.6) | 5.4 (3.4–8.5) | 16.4 (13.7–19.6) |
| Hispanic | 13.0 (11.4–14.9) | 4.6 (3.5–5.9) | 17.6 (16.0–19.3) |
| Education | |||
| Less than high school | 14.2 (12.3–16.2) | 4.8 (3.3–6.9) | 19.0 (16.9–21.3) |
| High school | 11.9 (9.3–15.2) | 4.0 (3.0–5.4) | 16.0 (13.0–19.4) |
| More than high school | 8.6 (7.8–9.5) | 2.5 (1.9–3.4) | 11.1 (10.3–12.0) |
Note: CI = confidence interval. Time period 2017–2020 covers January 2017 through March 2020 only.
Data source: 2017–March 2020 National Health and Nutrition Examination Survey.
Table 2
Appendix Table 2. Trends in age-adjusted prevalence of diagnosed, undiagnosed, and total diabetes among adults aged 18 years or older, United States, 2001–2020.
| Time Period | Diagnosed diabetesa Percentage (95% CI) |
Undiagnosed diabetes Percentage (95% CI) |
Total diabetesa Percentage (95% CI) |
|---|---|---|---|
| 2001–2004 | 7.1 (6.5–7.8) | 3.2 (2.7–3.8) | 10.3 (9.4–11.3) |
| 2003–2006 | 7.4 (6.7–8.1) | 2.8 (2.2–3.6) | 10.2 (9.3–11.2) |
| 2005–2008 | 7.7 (6.9–8.5) | 2.9 (2.4–3.6) | 10.6 (9.6–11.6) |
| 2007–2010 | 7.9 (7.1–8.7) | 3.2 (2.7–3.7) | 11.1 (10.1–12.2) |
| 2009–2012 | 8.1 (7.4–8.9) | 3.2 (2.6–3.8) | 11.3 (10.3–12.3) |
| 2011–2014 | 8.7 (8.1–9.4) | 2.7 (2.3–3.3) | 11.5 (10.7–12.3) |
| 2013–2016 | 9.4 (8.6–10.2) | 2.6 (2.2–3.1) | 12.0 (11.1–12.9) |
| 2015–2018 | 9.8 (9.0–10.7) | 2.9 (2.4–3.4) | 12.7 (11.6–13.8) |
| 2017–2020 | 10.1 (9.2–10.9) | 3.1 (2.6–3.8) | 13.2 (12.1–14.4) |
a p-value for linear trend <0.05.
Note: CI = confidence interval. Time period 2017–2020 covers January 2017 through March 2020 only.
Data source: 2001–March 2020 National Health and Nutrition Examination Survey.
Table 3
Appendix Table 3. Age-adjusted prevalence of diagnosed diabetes by race and ethnicity, education level, family income level, metropolitan residence, and sex among adults aged 18 years or older, United States, 2019–2021.
| Characteristic | Total Percentage (95% CI) |
Men Percentage (95% CI) |
Women Percentage (95% CI) |
|---|---|---|---|
| Race and Ethnicity | |||
| American Indian or Alaska Native | 13.6 (13.5–13.6) | 13.4 (13.3–13.4) | 13.7 (13.6–13.8) |
| Asian, non-Hispanic, overall | 9.1 (8.2–10.1) | 10.6 (9.0–12.3) | 7.8 (6.6–9.2) |
| Black, non-Hispanic | 12.1 (11.3–13.0) | 11.5 (10.4–12.7) | 12.5 (11.4–13.6) |
| Hispanic, overall | 11.7 (10.9–12.6) | 12.2 (11.1–13.5) | 11.3 (10.2–12.5) |
| White, non-Hispanic | 6.9 (6.6–7.1) | 7.7 (7.4–8.1) | 6.1 (5.8–6.4) |
| Education | |||
| Less than high school | 13.1 (12.2–14.1) | 12.7 (11.4–14.1) | 14.8 (12.3–14.9) |
| High school | 9.1 (8.6–9.5) | 9.6 (9.0–10.2) | 8.7 (8.0–9.3) |
| More than high school | 6.9 (6.7–7.2) | 7.9 (7.5–8.2) | 6.1 (5.8–6.5) |
| Family income to poverty ratio | |||
| Less than 100% FPL | 13.1 (12.1–14.1) | 12.2 (10.8–13.8) | 13.6 (12.4–15.0) |
| 100–299% FPL | 10.3 (9.9–10.8) | 11.0 (10.3–11.7) | 6.7 (6.1–7.3) |
| 300–499% FPL | 7.7 (7.3–8.3) | 8.8 (8.4–9.9) | 6.7 (6.0–7.2) |
| 500% FPL or more | 5.1 (4.9–5.4) | 6.3 (5.9–6.8) | 3.9 (3.6–4.3) |
| Metropolitan residence | |||
| Metropolitan | 8.1 (7.8–8.3) | 8.7 (8.3–9.0) | 7.6 (7.2–7.9) |
| Nonmetropolitan | 9.5 (8.7–10.4) | 10.5 (9.7–11.5) | 8.6 (7.6–9.8) |
Note: CI = confidence interval; FPL = federal poverty level.
Data sources: 2019–2021 National Health Interview Survey, except American Indian or Alaska Native data, which were from the Indian Health Service National Data Warehouse (2021 data only).
Table 4
Appendix Table 4. Age-adjusted incidence of diagnosed diabetes among adults aged 18 years or older, United States, 2018–2019.
| Characteristic | Rate per 1,000 (95% CI) |
|---|---|
| Total | 5.8 (4.9–6.7)a |
| Sex | |
| Men | 6.2 (5.0–7.7)a |
| Women | 5.4 (4.3–6.7)a |
| Metropolitan residence | |
| Metropolitan | 6.0 (5.1–7.0) |
| Nonmetropolitan | 4.3 (2.7–6.8) |
| Race and Ethnicity | |
| White, non-Hispanic | 4.6 (4.1–5.2) |
| Black, non-Hispanic | 6.8 (5.3–8.7) |
| Asian, non-Hispanic | 3.8 (2.4–6.0) |
| Hispanic | 6.8 (5.4–8.6) |
| Education | |
| Less than high school | 7.1 (5.5–9.1) |
| High school | 6.4 (5.4–7.7) |
| More than high school | 4.5 (3.9–5.1) |
a Rate calculated using 2019 data only.
Note: CI = confidence interval.
Data source: 2018–2019 National Health Interview Survey.
Table 5
Appendix Table 5. Age-adjusted prevalence of prediabetes according to various definitions of hyperglycemiaa among adults aged 18 years or older, United States, 2017–2020.
| Characteristic | Definition 1 Percentage (95% CI) |
Definition 2 Percentage (95% CI) |
Definition 3 Percentage (95% CI) |
|
|---|---|---|---|---|
| Total | 36.5 (34.2–38.8) | 22.2 (20.5–24.0) | 10.8 (9.7–11.9) | |
| Age, yearsa | ||||
| 18–44 | 27.8 (24.0–32.0) | 12.6 (10.7–14.8) | 5.8 (4.6–7.4) | |
| 45–64 | 44.8 (41.7–47.9) | 30.2 (26.5–34.3) | 13.8 (12.0–15.9) | |
| ≥65 | 48.8 (44.3–53.2) | 38.1 (34.5–41.8) | 20.8 (17.4–24.6) | |
| Sex | ||||
| Men | 41.0 (37.3–44.8) | 22.7 (20.4–25.3) | 11.4 (9.6–13.4) | |
| Women | 32.0 (28.9–35.2) | 21.6 (18.6–25.0) | 10.2 (8.3–12.4) | |
| Race and Ethnicity | ||||
| White, non-Hispanic | 35.7 (32.2–39.2) | 19.5 (16.6–22.8) | 9.2 (7.6–11.2) | |
| Black, non-Hispanic | 38.6 (35.4–41.8) | 32.8 (29.6–36.1) | 13.1 (11.0–15.6) | |
| Asian, non-Hispanic | 36.8 (32.4–41.5) | 27.8 (24.3–31.7) | 15.4 (12.7–18.6) | |
| Hispanic | 34.6 (31.2–38.2) | 22.7 (19.5–26.2) | 13.2 (11.1–15.6) | |
| Education | ||||
| Less than high school | 39.1 (34.3–44.2) | 26.8 (23.2–30.6) | 16.7 (13.4–20.6) | |
| High school | 41.9 (36.0–48.0) | 23.6 (20.4–27.3) | 12.4 (10.4–14.7) | |
| More than high school | 34.6 (32.4–37.0) | 21.1 (19.1–23.3) | 9.3 (7.8–11.2) | |
Note: CI = confidence interval. Time period 2017–2020 covers January 2017 through March 2020 only.
Data source: 2017–March 2020 National Health and Nutrition Examination Survey.
a Estimates are crude.
Definition 1: Any of: A1C 5.7–6.4% or fasting plasma glucose 100–125 mg/dL
Definition 2: Any of: A1C 5.7–6.4% or fasting plasma glucose 110–125 mg/dL
Definition 3: Both A1C 5.7–6.4% and fasting plasma glucose 100–125 mg/dL
Table 6
Appendix Table 6. Age-adjusted prevalence and awareness of prediabetes among adults aged 18 years or older, United States, 2017–2020.
| Characteristic | Prediabetesa Percentage (95% CI) |
Prediabetes awarenessb Percentage (95% CI) |
|---|---|---|
| Total | 36.5 (34.2–38.8) | 17.4 (13.7–21.9) |
| Sex | ||
| Men | 41.0 (37.3–44.8) | 15.9 (12.6–19.9) |
| Women | 32.0 (28.9–35.2) | 19.4 (13.2–27.5) |
| Race-ethnicity | ||
| White, non-Hispanic | 35.7 (32.2–39.2) | 16.0 (10.8–22.9) |
| Black, non-Hispanic | 38.6 (35.4–41.8) | 19.7 (15.1–25.1) |
| Asian, non-Hispanic | 36.8 (32.4–41.5) | 28.8 (18.5–42.0) |
| Hispanic | 34.6 (31.2–38.2) | 19.8 (14.8–26.1) |
| Education | ||
| Less than high school | 39.1 (34.3–44.2) | 16.3 (11.3–23.0) |
| High school | 41.9 (36.0–48.0) | 16.3 (9.6–26.3) |
| More than high school | 34.6 (32.4–37.0) | 18.3 (14.4–22.9) |
Note: CI = confidence interval. Time period 2017–2020 covers January 2017 through March 2020 only.
a Prediabetes was defined as fasting plasma glucose values of 100 to 125 mg/dL or A1C values of 5.7% to 6.4%.
b Prediabetes awareness was based on self-report and estimated only among adults with prediabetes.
Data source: 2017–March 2020 National Health and Nutrition Examination Survey.
Table 7
Appendix Table 7. Trends in age-adjusted prevalence and awareness of prediabetes among adults aged 18 years or older, United States, 2005–2020.
| Characteristic | Prediabetesa Percentage (95% CI) |
Prediabetes awarenessb,c Percentage (95% CI) |
|---|---|---|
| 2005–2008 | 33.6 (31.9–35.2) | 6.5 (5.3–7.9) |
| 2007–2010 | 36.3 (34.6–38.1) | 8.2 (6.7–9.9) |
| 2009–2012 | 35.2 (33.2–37.3) | 10.0 (8.3–11.9) |
| 2011–2014 | 33.0 (30.7–35.4) | 10.7 (9.0–12.5) |
| 2013–2016 | 33.3 (31.1–35.6) | 13.3 (11.0–16.0) |
| 2015–2018 | 36.8 (34.6–39.1) | 14.9 (12.4–17.8) |
| 2017–2020 | 36.5 (34.3–38.7) | 17.4 (13.8–21.6) |
Note: CI = confidence interval. Time period 2017–2020 covers January 2017 through March 2020 only.
a Prediabetes was defined as fasting plasma glucose values of 100 to 125 mg/dL or A1C values of 5.7% to 6.4%.
b Prediabetes awareness was based on self-report and estimated only among adults with prediabetes.
c p-value for linear trend <0.05.
Data source: 2005–March 2020 National Health and Nutrition Examination Survey.
Table 8
Appendix Table 8. Crude percentage of factors associated with diabetes-related complications among adults aged 18 years or older with diagnosed diabetes, United States, 2017–2020.
| Risk factors for diabetes-related complications | Percentage (95% CI) |
|---|---|
| Smoking | |
| Current tobacco user based on self-report or serum cotinine >10 ng/mL | 22.1 (18.7–26.0) |
| Current cigarette smoker based on self-report | 14.6 (12.2–17.3) |
| Former cigarette smoker | 36.0 (30.5–41.8) |
| Overweight and obesity, according to body mass index (BMI) | |
| BMI ≥25.0 kg/m2 | 89.8 (87.2–92.0) |
| BMI 25.0–29.9 kg/m2 | 26.9 (24.0–30.0) |
| BMI 30.0–39.9 kg/m2 | 47.1 (43.3–51.0) |
| BMI ≥40.0 kg/m2 | 15.7 (12.4–19.7) |
| Physical inactivity | 31.9 (28.5–35.6) |
| A1C | |
| A1C≥7.0% | 47.4 (41.1–53.8) |
| A1C 7.0–7.9% | 22.9 (18.7–27.8) |
| A1C 8.0–9.0% | 11.5 (8.3–15.7) |
| A1C>9.0% | 13.0 (10.5–15.9) |
| High blood pressure | |
| Blood pressure ≥130/80 mmHg or taking antihypertensive medication | 80.6 (77.5-83.3) |
| Blood pressure ≥140/90 mmHg or taking antihypertensive medication | 70.8 (66.8–74.5) |
| High cholesterol, according to non-HDL cholesterol | |
| Non-HDL ≥130 mg/dL | 39.5 (33.1–46.2) |
| Non-HDL 130–159 mg/dL | 19.9 (16.3–24.1) |
| Non-HDL 160–189 mg/dL | 11.5 (8.1–16.1) |
| Non-HDL ≥190 mg/dL | 8.0 (5.7–11.1) |
Note: CI = confidence interval. Former cigarette smoker was based on serum cotinine levels ≤10 ng/mL, a history of smoking at least 100 cigarettes in their lifetime, and a self-report of no current cigarette smoking. Physical inactivity was based on self-report of less than 10 minutes per week of moderate or vigorous activity in each of the physical activity categories of work, leisure time, and transportation.
Data source: 2017–March 2020 National Health and Nutrition Examination.
Table 9
Appendix Table 9. Distribution of A1C levels among adults with diagnosed diabetes aged 18 years or older, overall and by age group, United States, 2017–2020.
| A1C | Total | 18–44 years | 45–64 years | ≥65 years |
|---|---|---|---|---|
| <6.5% | 32.6 (27.2–38.6) | 48.1 (34.1–62.3) | 28.5 (19.7–39.3) | 32.8 (28.8–37.0) |
| 6.5%–6.9% | 20.0 (16.5–24.0) | 6.1 (2.9–12.6) | 19.3 (13.8–26.2) | 24.3 (19.4–30.0) |
| 7.0%–7.9% | 22.9 (18.7–27.8) | 15.3 (8.1–26.9) | 22.5 (16.2–30.3) | 25.5 (20.9–30.7) |
| 8.0%–8.9% | 11.0 (7.9–15.1) | 11.1 (4.2–26.1) | 12.8 (7.1–22.2) | 9.1 (6.8–12.1) |
| 9.0%–9.9% | 6.9 (4.8–9.8) | 9.0 (3.5–21.5) | 7.6 (4.4–12.8) | 5.7 (3.4–9.4) |
| ≥10.0% | 6.6 (5.0–8.5) | 10.4 (5.2–19.6) | 9.4 (6.6–13.1) | 2.6 (1.5–4.8) |
Note: Estimates are crude percentages and 95% confidence intervals. Time period 2017–2020 covers January 2017 through March 2020 only.
Data source: 2017–March 2020 National Health and Nutrition Examination Survey.
Table 10
Appendix Table 10. Crude percentage of factors associated with prevention of diabetes-related complications among adults aged 18 years or older with diagnosed diabetes, United States, 2017–2020.
| Preventive factors | Percentage (95% CI) |
|---|---|
| At least one usual source of diabetes care | 78.8 (73.8-83.0) |
| At least 150 minutes per week of leisure-time physical activity | 24.1 (19.5-29.3) |
| Managing or losing weight to lower their risk for developing certain diseases | 73.1 (69.5-76.4) |
| Among adults aged 40–75 years, % on statin therapy | 57.8 (52.7-62.7) |
Note: CI = confidence interval.
Data source: 2017–March 2020 National Health and Nutrition Examination Surveys.
Table 11
Appendix Table 11. Crude prevalence of chronic kidney disease among adults aged 18 years or older, overall and by race and ethnicity, United States, 2017–2020.
| Characteristic | CKD stages 1–4 Percentage (95% CI) |
CKD stages 3–4 Percentage (95% CI) |
CKD awareness, a Percentage (95% CI) |
|---|---|---|---|
| CKD definition 1 b | |||
| Total | 39.2 (35.7–42.9) | 15.7 (13.1–18.7) | 32.5 (21.8–45.4) |
| Race-ethnicity | |||
| White, non-Hispanic | 38.2 (31.7–45.2) | 17.2 (13.4–21.9) | 33.5 (19.5–51.1) |
| Black, non-Hispanic | 46.6 (41.5–51.7) | 23.1 (18.2–29.1) | 31.2 (20.0–45.2) |
| Asian, non-Hispanic | 35.1 (25.9–45.6) | -- d | -- d |
| Hispanic | 38.5 (31.5–46.1) | 8.9 (6.1–12.9) | 29.9 (17.6–46.0) |
| Characteristic | CKD stages 1–4 Percentage (95% CI) |
CKD stages 3–4 Percentage (95% CI) |
CKD awareness, a Percentage (95% CI) |
|---|---|---|---|
| CKD definition 2 c | |||
| Total | 40.9 (36.8–45.0) | 18.2 (15.0–22.0) | 29.7 (20.2–41.4) |
| Race-ethnicity | |||
| White, non-Hispanic | 40.1 (33.2–47.6) | 20.7 (15.9–26.5) | 30.3 (17.9–46.4) |
| Black, non-Hispanic | 44.2 (40.0–48.5) | 19.0 (14.7–24.3) | 38.1 (25.8–52.2) |
| Asian, non-Hispanic | 37.9 (28.9–47.7) | 9.9 (5.3–17.8) | -- d |
| Hispanic | 39.7 (31.8–48.3) | 10.6 (7.1–15.5) | 25.0 (12.6–43.4) d |
Note: CKD = chronic kidney disease. Time period 2017–2020 covers January 2017 through March 2020 only.
a Among CKD stages 3–4 only.
b CKD based on 2021 CKD Epidemiology Collaboration serum creatinine-only GFR estimating equation, including age and sex only.
c CKD based on 2009 CKD Epidemiology Collaboration serum creatinine-only GFR estimating equation, including age, sex, and Black race.
d Estimates were statistically unreliable based on relative standard error >30%.
Data source: 2017–March 2020 National Health and Nutrition Examination Survey.